Vaccination coverage in children with juvenile idiopathic arthritis, inflammatory bowel diseases, and healthy peers:

Elizaveta Makarova1, Aygul Khabirova2, Natalia Volkova3

  • 1Department of Polyclinic Pediatrics, Saint-Petersburg State Pediatric Medical University, Saint-Petersburg 194100, Russia.

Insights

Children with juvenile idiopathic arthritis (JIA) and inflammatory bowel disease (IBD) have lower vaccine coverage. Physician encouragement and clear communication are crucial for improving vaccination rates in these vulnerable pediatric populations.

Area of Science:

  • Pediatric Rheumatology
  • Pediatric Gastroenterology
  • Immunology
  • Public Health

Background:

  • Children with immune-mediated diseases like juvenile idiopathic arthritis (JIA) and inflammatory bowel disease (IBD) face increased infection risk.
  • This heightened risk stems from disease-related immune dysfunction and the use of immunosuppressive medications.

Purpose of the Study:

  • To assess and compare vaccine coverage in children with IBD and JIA against that of healthy children.
  • To identify factors influencing vaccination rates in these pediatric patient groups.

Main Methods:

  • A cross-sectional study utilizing an electronic online questionnaire survey.
  • Data collected from legal representatives of 190 children: 81 with JIA, 51 with IBD, and 58 healthy controls (HC).

Main Results:

  • Patients with JIA and IBD exhibited lower vaccine coverage compared to healthy children.
  • Medical conditions were the primary reason for incomplete vaccinations in JIA and IBD patients.
  • Physician encouragement for vaccination was lowest in JIA patients, impacting coverage.

Conclusions:

  • Pediatric patients with JIA and IBD demonstrate suboptimal vaccine coverage.
  • Effective physician communication and personalized vaccination strategies are essential for improving coverage in chronically ill children.
  • Current vaccination promotion approaches for healthy children may not be optimal for immune-mediated disease populations.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
44.9K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
325
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
150
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
212
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
660
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
410